Manipal Health Enterprises IPO
Price band
–
About Manipal Health Enterprises
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care.
Strengths
- A large network of multi-speciality hospitals supported by a wide base of doctors.
- Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
- Strong presence across key regions with ongoing expansion plans.
- Significant share of revenue from insurance and institutional payors.
- Established track record of growth in patient volumes and operations.
Risks
- High dependence on insurance and third-party administrators for revenue.
- Delays in payments from government schemes can impact cash flows.
- Expansion into new regions may face operational and market challenges.
- Failure to attract sufficient patients can lead to underutilised capacity.
- High outstanding receivables may affect working capital and liquidity.
Use of proceeds
| Repayment of borrowings | ₹5378 (67.23%) Cr |
| General corporate purposes | ₹2048 (25.59%) Cr |
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.